Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huzhang Tongfeng is a Traditional Chinese Medicine (TCM) formulation, typically administered as granules, developed for the treatment of acute gouty arthritis. It is based on the therapeutic principle of clearing heat, removing dampness, and dredging collaterals (Qin-Re Li-Shi Tong-Luo). The formulation's primary component is *Polygonum cuspidatum* (Huzhang), which is recognized for its anti-inflammatory and analgesic properties, often attributed to active compounds such as resveratrol and emodin. Clinical evaluation, primarily conducted by the Yueyang Integrated Traditional Chinese and Western Medicine Hospital, focuses on the formulation's ability to alleviate joint pain, swelling, and dysfunction associated with gout flares while potentially lowering serum uric acid levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huzhang Tongfeng.